Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience

• Published in: International journal of cardiology Vol. 323; pp. 276 - 280
• Main Authors: Schiavone, Marco, Gasperetti, Alessio, Mancone, Massimo, Curnis, Antonio, Mascioli, Giosuè, Mitacchione, Gianfranco, Busana, Mattia, Sabato, Federica, Gobbi, Cecilia, Antinori, Spinello, Galli, Massimo, Forleo, Giovanni Battista
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 15.01.2021; Published by Elsevier B.V
• Subjects: Administration, Oral; Age Factors; Aged; Anticoagulants - therapeutic use; Anticoagulation; Coagulopathy; Cohort Studies; Coronary Artery Disease - epidemiology; COVID-19; COVID-19 - mortality; COVID-19 - virology; COVID-19 Drug Treatment; Female; Fibrin Fibrinogen Degradation Products - analysis; Heparin; Heparin - therapeutic use; Hospitalization; Humans; Italy - epidemiology; Male; Microthrombosis; Middle Aged; Multivariate Analysis; Oral anticoagulants; Oxygen - blood; Respiratory Insufficiency - drug therapy; Respiratory Insufficiency - mortality; Sex Factors; Short Communication; Italy; COVID-19; Anticoagulation; Heparin; Microthrombosis; Coagulopathy; Oral anticoagulants

Since the body of evidence addressing the coagulation derangements caused by Coronavirus disease (COVID-19) has been constantly growing, we investigated whether pre-hospitalization oral anticoagulation (OAC) or in-hospital heparin treatment could have a protective role among COVID-19 patients. In th...